Clinical trial Recruiting at 18 sites Interventional Ages 18 and up

Using ShockWAVE technology to treat severely calcified coronary artery disease

Official title: Intracoronary Stenting and Additional Results Achieved by ShockWAVE Coronary Lithotripsy: A Randomized, Multicenter Study About the Additional Benefit of Coronary Lithotripsy

Run by Deutsches Herzzentrum Muenchen · NCT06369142 · Data updated 2026-11-12

This study is testing a new technology called ShockWAVE to see if it can help people with severely calcified coronary artery disease get better results from stenting compared to standard methods.

More Coronary Artery Disease trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment666 (estimated)
SponsorDeutsches Herzzentrum Muenchen
Academic / other
Locations22 sites (Heidelberg, Baden-Wurttemberg and 21 other locations)
StatusRecruiting
StartedJuly 1, 2024
Main results expectedApril 30, 2027
Study endsJuly 31, 2027
Registry record updatedJanuary 6, 2026
Trial IDNCT06369142 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with severe calcification in coronary lesions and evidence of ischemia.

Probably not a fit

Patients with recent myocardial infarction, significant thrombus in the target vessel, or limited life expectancy due to other diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the efficacy and safety of intravascular lithotripsy (IVL) compared to traditional methods for preparing severely calcified coronary lesions before stenting. The study focuses on patients with significant coronary artery disease who have not responded adequately to optimal drug therapy. Participants will undergo procedures to assess the effectiveness of IVL in improving outcomes related to coronary interventions. The trial aims to provide insights into the economic benefits of using IVL in clinical practice.

Why it matters

Potential benefit: If successful, this approach could improve treatment outcomes for patients with severely calcified coronary artery disease.

How similar studies have gone: Other studies have shown promising results with similar lithotripsy techniques, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. age ≥18 years and able to give informed consent
2. written informed consent to participate in the clinical trial
3. typical angina pectoris or non-invasive evidence of relevant ischemia under optimal drug therapy
4. angiographic evidence of coronary artery disease
5. de novo lesion in a native coronary artery
6. target vessel diameter 2.5-4 mm
7. severe calcification of the target lesion (angiographic grade 3)

Exclusion Criteria:

1. myocardial infarction \<1 week
2. thrombus in the target vessel
3. life expectancy due to other disease \<1 year
4. simultaneous participation in a clinical trial with medical devices or medicinal products that has not yet been completed
5. pregnancy (current, suspected, planned) or positive pregnancy test

Where it's running

  • Universitätsklinikum Mannheim GmbH, I. Medizinische Klinik, Kardiologie, Angiologie, Hämostaseologie, Internistische Intensivmedizin
    Mannheim, Baden-Wurttemberg, Germany
    Recruiting
  • Hegau-Bodensee-Klinikum Singen GmbH, I. Medizinsche Klinik (Kardiologie und internistische Intensivmedizin)
    Singen, Baden-Wurttemberg, Germany
    Recruiting
  • Universitätsklinikum Ulm
    Ulm, Baden-Wurttemberg, Germany
    Recruiting
  • Universitätsklinikum Augsburg A.ö.R.
    Augsburg, Bavaria, Germany
    Recruiting
  • Helios Amper-Klinikum Dachau, Kardiologie und Pneumologie
    Dachau, Bavaria, Germany
    Recruiting
  • Klinikum Landkreis Erding
    Erding, Bavaria, Germany
    Recruiting
Show 16 more locations
  • Klinikum Ingolstadt
    Ingolstadt, Bavaria, Germany
    Recruiting
  • Deutsches Herzzentrum München
    Munich, Bavaria, Germany
    Recruiting
  • Augustinum Klinik München
    München, Bavaria, Germany
    Recruiting
  • Universitäres Herz- und Gefäßzentrum
    Hamburg, Free and Hanseatic City of Hamburg, Germany
    Recruiting
  • Krankenhaus Landshut-Achdorf, LAKUMED Kliniken
    Landshut, Germany, Germany
    Recruiting
  • Klinikum Hersfeld Rotenburg GmbH Herz-Kreislauf-Zentrum Institut für Klinische Forschung
    Rotenburg an der Fulda, Hesse, Germany
    Recruiting
  • Herz- und Diabeteszentrum Nordrhein-Westfalen
    Bad Oeynhausen, North Rhine-Westphalia, Germany
    Recruiting
  • Elisabeth Krankenhaus Essen Contilia Herz- und Gefäßzentrum Klinik für Kardiologie und Angiologie Kardiovaskuläres Studienzentrum
    Essen, North Rhine-Westphalia, Germany
    Recruiting
  • Krankenhaus Barmherzige Brüder Trier
    Trier, Rhineland-Palatinate, Germany
    Recruiting
  • Asklepios Klinik Bad Oldesloe Innere Medizin, Kardiologie und Intensivmedizin
    Bad Oldesloe, Schleswig-Holstein, Germany
    Recruiting
  • Klinik für Kardiologie, Angiologie und Intensivmedizin Deutsches Herzzentrum der Charité
    Berlin, State of Berlin, Germany
    Recruiting
  • BG Klinikum Unfallkrankenhaus Berlin gGmbH
    Berlin, State of Berlin, Germany
    Recruiting
  • Universitätsklinikum Heidelberg, Klinik für Kardiologie, Angiologie und Pneumologie
    Heidelberg, Baden-Wurttemberg, Germany
    Active not recruiting
  • Cardiologikum Herzklinik Ulm MVZ
    Ulm, Baden-Wurttemberg, Germany
    Active not recruiting
  • Klinikum der Ludwig-Maximilians-Universität München
    München, Bavaria, Germany
    Not yet recruiting
  • Herzzentrum Dresden GmbH Universitätsklinik an der Technischen Universität Dresden
    Dresden, Saxony, Germany
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.